These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 8112647

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. The beta-core fragment of human chorionic gonadotropin: biochemical background and clinical application.
    Schutter EM, Mulder C, van Kamp GJ, Kenemans P.
    Anticancer Res; 1997; 17(2B):1255-72. PubMed ID: 9137483
    [Abstract] [Full Text] [Related]

  • 43. The free beta-subunit of human chorionic gonadotropin as a prognostic factor in renal cell carcinoma.
    Hotakainen K, Ljungberg B, Paju A, Rasmuson T, Alfthan H, Stenman UH.
    Br J Cancer; 2002 Jan 21; 86(2):185-9. PubMed ID: 11870503
    [Abstract] [Full Text] [Related]

  • 44. Validation of referral guidelines for women with pelvic masses.
    Im SS, Gordon AN, Buttin BM, Leath CA, Gostout BS, Shah C, Hatch KD, Wang J, Berman ML.
    Obstet Gynecol; 2005 Jan 21; 105(1):35-41. PubMed ID: 15625139
    [Abstract] [Full Text] [Related]

  • 45. [Clinical value of serum CA19-9, CA125 and CP2 in mucinous ovarian tumor: a retrospective study of 273 patients].
    Dong L, Cui H, Li XP, Sun LF, Chang XH, Liang XD, Zhu HL.
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jan 21; 43(1):5-8. PubMed ID: 18366923
    [Abstract] [Full Text] [Related]

  • 46. Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer.
    Cole LA, Sutton JM.
    J Reprod Med; 2004 Jul 21; 49(7):545-53. PubMed ID: 15305826
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
    Wu X, Lu XH, Xu T, Qian JM, Zhao P, Guo XZ, Yang XO, Jiang WJ.
    Chin J Dig Dis; 2006 Jul 21; 7(3):170-4. PubMed ID: 16808798
    [Abstract] [Full Text] [Related]

  • 49. Urine free beta hCG and beta core in pregnancies affected by Down's syndrome.
    Spencer K, Aitken DA, Macri JN, Buchanan PD.
    Prenat Diagn; 1996 Jul 21; 16(7):605-13. PubMed ID: 8843469
    [Abstract] [Full Text] [Related]

  • 50. Screening for ovarian cancer: the preliminary experience of a familial ovarian cancer center.
    Muto MG, Cramer DW, Brown DL, Welch WR, Harlow BL, Xu H, Brucks JP, Tsao SW, Berkowitz RS.
    Gynecol Oncol; 1993 Oct 21; 51(1):12-20. PubMed ID: 8244166
    [Abstract] [Full Text] [Related]

  • 51. Substantial urinary concentrations of material resembling beta-core fragment of chorionic gonadotropin beta-subunit in mid-menstrual cycle.
    Neven P, Iles RK, Howes I, Sharma K, Shepherd JH, Edwards R, Collins WP, Chard T.
    Clin Chem; 1993 Sep 21; 39(9):1857-60. PubMed ID: 8375060
    [Abstract] [Full Text] [Related]

  • 52. Ovarian cancer tumor marker behavior in asymptomatic healthy women: implications for screening.
    Crump C, McIntosh MW, Urban N, Anderson G, Karlan BY.
    Cancer Epidemiol Biomarkers Prev; 2000 Oct 21; 9(10):1107-11. PubMed ID: 11045795
    [Abstract] [Full Text] [Related]

  • 53. Carcinoembryonic antigen in women with isolated pelvic masses. Clinical utility?
    Roman LD, Muderspach LI, Burnett AF, Morrow CP.
    J Reprod Med; 1998 May 21; 43(5):403-7. PubMed ID: 9610461
    [Abstract] [Full Text] [Related]

  • 54. Urinary gonadotropin fragments (UGF) in cancers of the female reproductive system. I. Sensitivity and specificity, comparison with other markers.
    Cole LA, Schwartz PE, Wang YX.
    Gynecol Oncol; 1988 Sep 21; 31(1):82-90. PubMed ID: 3044936
    [Abstract] [Full Text] [Related]

  • 55. [Human chorionic gonadotropin beta-core fragment (hCGbetacf)].
    Okamoto T.
    Nihon Rinsho; 2010 Jul 21; 68 Suppl 7():803-6. PubMed ID: 20963909
    [No Abstract] [Full Text] [Related]

  • 56. Effect of urinary proteins on in vitro immunological tests for pregnancy.
    Cadoff E, Daniel A.
    Am J Med Technol; 1983 Mar 21; 49(3):173-6. PubMed ID: 6837617
    [Abstract] [Full Text] [Related]

  • 57. Diurnal variation of urinary "hCG beta subunit core fragment" production evaluated in patients with gynecological neoplasms.
    Neven P, Iles RK, Carter PG, Shepherd JH, Chard T.
    Clin Chem; 1994 Mar 21; 40(3):484-5. PubMed ID: 7510595
    [No Abstract] [Full Text] [Related]

  • 58. CA 125 in preoperative evaluation of pelvic masses.
    Pyrgiotis E, Salamalekis E, Loghis C, Dima C, Zourlas PA.
    Eur J Gynaecol Oncol; 1993 Mar 21; 14(4):279-82. PubMed ID: 8344320
    [Abstract] [Full Text] [Related]

  • 59. Urinary gonadotropin fragment measurements in patients with lung and esophageal disease.
    D'Agostino RS, Cole LA, Ponn RB, Stern H, Schwartz PE.
    J Surg Oncol; 1992 Mar 21; 49(3):147-50. PubMed ID: 1548888
    [Abstract] [Full Text] [Related]

  • 60. Improved methods for detecting beta-core in normal and cancer patient urines.
    Tanaka A, Cole LA.
    Clin Chem; 1994 Dec 21; 40(12):2317-8. PubMed ID: 7988019
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.